Table 3

Relationship between evidence-based recommendations and 6-month survival in the overall population and among patients with STEMI

	OR	95% CI		p Value
Overall population
Coronary artery bypass graft surgery	0.53	0.34	0.82	0.005
PCI	0.63	0.48	0.81	<0.001
Statin therapy	0.74	0.63	0.88	<0.001
Clopidogrel	0.80	0.67	0.95	0.01
Intravenous glycoprotein IIb/IIIa inhibitor	0.83	0.66	1.05	0.12
β-Blocker	0.86	0.71	1.05	0.15
Referral to cardiac rehabilitation	0.88	0.73	1.05	0.15
ACE inhibitor	0.91	0.77	1.07	0.25
Aspirin	0.97	0.73	1.29	0.83
Cardiac catheterisation	1.14	0.92	1.40	0.23
Patients with STEMI
Coronary artery bypass graft	0.53	0.25	1.10	0.09
PCI	0.62	0.38	0.99	0.05
Intravenous glycoprotein IIb/IIIa inhibitor	0.63	0.43	0.92	0.02
Statin	0.67	0.49	0.90	0.01
Clopidogrel	0.78	0.57	1.08	0.14
β-Blocker	0.83	0.58	1.19	0.32
Referral to cardiac rehabilitation	0.84	0.62	1.14	0.26
ACE inhibitor	0.95	0.70	1.29	0.76
Aspirin	0.96	0.55	1.68	0.89
Fibrinolysis	0.96	0.70	1.30	0.77
Cardiac catheterisation	1.32	0.90	1.94	0.16